Wait, We Have Additional Free Gifts for You

Company Overview Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharmaceutical company focused on neuroscience, recently thrust into the spotlight after a major late-stage trial setback.

Daily Financial Update Good Monday morning—let’s cut through the noise and get you up to speed on what really matters. Opening Recap Market Pulse: AI

Overview & Barzolvolimab Breakthrough Celldex Therapeutics (NASDAQ: CLDX) is a clinical-stage biotech focused on immunology, and it recently drew significant attention after unveiling compelling results